ILANIT 2023

Macrophage activation: A new insight

Michal Levy Orli Turgeman Raymond Kaempfer
Biochemistry and Molecular Biology, The Hebrew University, Israel

The inflammatory response is indispensable for protective immunity, yet virulent pathogens, whether bacteria or viruses, often elicit greatly excessive inflammation, ‘cytokine storm’, harmful to the host. Full T-cell activation requires interaction of costimulatory receptors B7-1 (CD80) and B7-2 (CD86), expressed on antigen-presenting cells (APC), with CD28 expressed on the T cell. It is currently thought that the B7/CD28 costimulatory axis signals solely in one direction, from the APC into the T cell. We focus on a brand-new basic concept: retrosignaling through the B7/CD28 axis, backwards into the APC, controls Toll-like receptor (TLR)-mediated inflammatory cytokine responses of APC. Our finding is that induction by a broad set of TLR agonists of APC-specific cytokines such as IL-1β and IL-1α depends on the presence of T cells. We could show that cytokine expression mediated by TLR agonists in APC is abolished completely when depleting human PBMC from CD3-positive T cells. However, whether T cells signal back into the APC in a direct manner through the B7/CD28 axis, or whether they signal indirectly through cytokines from T cells remains a central question. In addition, if signaling by T cells to APC is indirect, which cytokines are involved? For TLR2/6 inducer Zymosan we could show that IL-1α and IL-1β expression is dependent on inflammatory cytokine IFN-γ, expressed specifically by T cells. Hence, induction through TLR2/6, signaling is indirect and not direct through the B7/CD28 costimulatory axis and depends on IFN-γ.